Junbo He

789 total citations
19 papers, 546 citations indexed

About

Junbo He is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Junbo He has authored 19 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Junbo He's work include Cancer-related molecular mechanisms research (5 papers), Epigenetics and DNA Methylation (4 papers) and RNA modifications and cancer (4 papers). Junbo He is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Epigenetics and DNA Methylation (4 papers) and RNA modifications and cancer (4 papers). Junbo He collaborates with scholars based in China, United States and Canada. Junbo He's co-authors include Min Xu, Aihua Gong, F. Du, Ying Lu, Jian Zeng, Xu Xiao, Changchun Zhu, Saijun Fan, Dawei Wang and Jixiang Chen and has published in prestigious journals such as PLoS ONE, Free Radical Biology and Medicine and British Journal of Cancer.

In The Last Decade

Junbo He

18 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junbo He China	12	408	204	101	58	56	19	546
Shengchun Wang China	13	713 1.7×	466 2.3×	98 1.0×	35 0.6×	60 1.1×	36	965
Ye‐Lin Liang China	12	410 1.0×	304 1.5×	104 1.0×	17 0.3×	54 1.0×	21	541
Shunli Shen China	16	349 0.9×	249 1.2×	187 1.9×	17 0.3×	61 1.1×	32	689
Bowen Yuan China	8	301 0.7×	103 0.5×	137 1.4×	10 0.2×	75 1.3×	14	418
Sarah McDonald United Kingdom	9	343 0.8×	112 0.5×	231 2.3×	22 0.4×	48 0.9×	19	475
Huafu Li China	10	401 1.0×	252 1.2×	110 1.1×	7 0.1×	104 1.9×	18	595
Katsuya Nakai Japan	12	336 0.8×	168 0.8×	369 3.7×	52 0.9×	114 2.0×	29	656
Huinian Zhou China	10	390 1.0×	207 1.0×	146 1.4×	27 0.5×	90 1.6×	27	559
Hao Cui China	11	213 0.5×	113 0.6×	44 0.4×	32 0.6×	27 0.5×	41	414

Countries citing papers authored by Junbo He

Since Specialization

Citations

This map shows the geographic impact of Junbo He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbo He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbo He more than expected).

Fields of papers citing papers by Junbo He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junbo He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbo He. The network helps show where Junbo He may publish in the future.

Co-authorship network of co-authors of Junbo He

This figure shows the co-authorship network connecting the top 25 collaborators of Junbo He. A scholar is included among the top collaborators of Junbo He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junbo He. Junbo He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

He, Junbo, et al.. (2025). GGCT participates in the malignant process of hepatocellular cancer cells by regulating the PTEN/PI3K/AKT pathway through binding to EZH2. Discover Oncology. 16(1). 129–129.

He, Junbo, et al.. (2024). Digital transformation and supply chain efficiency improvement: An empirical study from a-share listed companies in China. PLoS ONE. 19(4). e0302133–e0302133. 19 indexed citations

Zhu, Tong, Junbo He, Xueying Zhang, et al.. (2022). D-galactose protects the intestine from ionizing radiation-induced injury by altering the gut microbiome. Journal of Radiation Research. 63(6). 805–816. 12 indexed citations

Yang, Hongqiong, et al.. (2021). The Efficacy of Ramucirumab in the Treatment of Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of RCTs. Gastroenterology Research and Practice. 2021. 1–8. 1 indexed citations

Wang, Huizhi, Jie Li, Junbo He, et al.. (2020). Methyl-CpG-binding protein 2 drives the Furin/TGF-β1/Smad axis to promote epithelial–mesenchymal transition in pancreatic cancer cells. Oncogenesis. 9(8). 76–76. 16 indexed citations

Wang, Huizhi, Wen Feng, Junbo He, et al.. (2020). Methyl-CpG-binding domain 3 inhibits stemness of pancreatic cancer cells via Hippo signaling. Experimental Cell Research. 393(1). 112091–112091. 7 indexed citations

Zhu, Changchun, Chang Ge, Junbo He, et al.. (2020). Identification of Key Genes and Pathways Associated With Irradiation in Breast Cancer Tissue and Breast Cancer Cell Lines. Dose-Response. 18(2). 3794411845–3794411845. 5 indexed citations

Liu, Huadong, et al.. (2019). MicroRNA-133b regulates the growth and migration of vascular smooth muscle cells by targeting matrix metallopeptidase 9. Pathology - Research and Practice. 215(5). 1083–1088. 8 indexed citations

Liu, Yawen, Wen Feng, Wen‐Yu Liu, et al.. (2019). Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis. Journal of Cancer. 10(16). 3746–3756. 60 indexed citations

10.

Liu, Huadong, et al.. (2019). Significant role and mechanism of microRNA-143-3p/KLLN axis in the development of coronary heart disease.. PubMed. 11(6). 3610–3619. 10 indexed citations

11.

Cui, Ming, Huiwen Xiao, Yuan Li, et al.. (2019). Sexual Dimorphism of Gut Microbiota Dictates Therapeutics Efficacy of Radiation Injuries. Advanced Science. 6(21). 1901048–1901048. 48 indexed citations

12.

Ge, Lu, Huizhi Wang, Xu Xiao, et al.. (2019). PRMT5 promotes epithelial‐mesenchymal transition via EGFR‐β‐catenin axis in pancreatic cancer cells. Journal of Cellular and Molecular Medicine. 24(2). 1969–1979. 40 indexed citations

13.

Lu, Lu, Mian Jiang, Changchun Zhu, Junbo He, & Saijun Fan. (2018). Amelioration of whole abdominal irradiation-induced intestinal injury in mice with 3,3′-Diindolylmethane (DIM). Free Radical Biology and Medicine. 130. 244–255. 51 indexed citations

14.

Zhang, Youli, Meng Zhou, Hong Wei, et al.. (2017). Furin promotes epithelial-mesenchymal transition in pancreatic cancer cells via Hippo-YAP pathway. International Journal of Oncology. 50(4). 1352–1362. 30 indexed citations

15.

Chen, Jixiang, Xu Xiao, Dawei Wang, et al.. (2017). YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells. Cell Cycle. 16(23). 2259–2271. 167 indexed citations

16.

Zhou, Meng, Youli Zhang, Hong Wei, et al.. (2017). Furin inhibitor D6R suppresses epithelial-mesenchymal transition in SW1990 and PaTu8988 cells via the Hippo-YAP signaling pathway. Oncology Letters. 15(3). 3192–3196. 7 indexed citations

17.

Xu, Min, Junbo He, Jie Li, et al.. (2016). Methyl-CpG-binding domain 3 inhibits epithelial–mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling. British Journal of Cancer. 116(1). 91–99. 18 indexed citations

18.

Xu, Min, Chunli Zhang, Junbo He, et al.. (2016). ADAM17 promotes epithelial-mesenchymal transition via TGF-β/Smad pathway in gastric carcinoma cells. International Journal of Oncology. 49(6). 2520–2528. 28 indexed citations

19.

Xu, Min, Jie Li, Junbo He, et al.. (2016). MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells. Oncotarget. 7(12). 14476–14485. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact